Terns Pharmaceuticals Inc (STU:430)
€ 5.6 0.05 (0.9%) Market Cap: 470.26 Mil Enterprise Value: 113.82 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 39/100

Terns Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript

May 15, 2023 / 06:00PM GMT
Release Date Price: €11.56 (+0.52%)
Silvan Türkcan
JMP Securities LLC - Analyst

Okay, welcome back. My name is Silvan Türkcan. I cover precision medicines here at JMP Securities. It's my pleasure to host Erin Quirk --

Mark Vignola
Terns Pharmaceuticals, Inc. - CFO

Kerry Russell.

Silvan Türkcan
JMP Securities LLC - Analyst

Sorry, Kerry Russell and Mark Vignola from Terns Pharmaceuticals. Thank you so much for joining us today.

Mark Vignola
Terns Pharmaceuticals, Inc. - CFO

Thanks so much for having us. It's great to be here.

Kerry Russell
Terns Pharmaceuticals, Inc. - Chief Medical Officer, Metabolic

Thank you, Silvan.

Questions & Answers

Silvan Türkcan
JMP Securities LLC - Analyst

Terns is focused on developing, obviously, small molecules for -- with different mechanisms of action about a host of indications, and -- but some investors may still know you as the NASH company or a NASH company. So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot